PFE Nov 2025 23.000 call
| Previous Close | 7.00 |
| Open | 7.00 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 23.00 |
| Expire Date | 2025-11-21 |
| Day's Range | 7.00 - 7.00 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 8 |
Business WirePfizer Highlights Diverse Oncology Portfolio and Combination Approaches at ESMO 2024
NEW YORK, September 11, 2024--Pfizer Inc. (NYSE: PFE) continues to showcase potential practice-changing research and next-generation candidates across its robust Oncology portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, being held September 13-17 in Barcelona. Data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts, including more than 10 oral and mini-oral presentations, will be presented across the company’s tumor areas
ZacksWhy Pfizer (PFE) Outpaced the Stock Market Today
In the most recent trading session, Pfizer (PFE) closed at $29.74, indicating a +1.11% shift from the previous trading day.
ZacksRelay Stock Soars on Upbeat Data From Breast Cancer Study
RLAY stock soars on positive interim efficacy data from the early-stage study of its doublet therapy, RLY-2608 in combination with Faslodex, for treating MBC.
